Factors influencing D30 CD3 chimerism
| . | D30 CD3 chimerism . | . | |
|---|---|---|---|
| . | >50% . | ≤50% . | P . |
| Age of product, n (%) | <.001 | ||
| <48 h | 202 (86) | 37 (59.7) | |
| ≥48 h | 33 (14) | 25 (40.3) | |
| %TNC viability-7AAD, n (%) | |||
| <90% | 60 (25.5) | 27 (43.5) | .008 |
| ≥90% | 175 (74.5) | 35 (56.5) | |
| Product origin, n (%) | .03 | ||
| Domestic | 133 (56.6) | 25 (40.3) | |
| International | 102 (43.4) | 37 (59.7) | |
| . | D30 CD3 chimerism . | . | |
|---|---|---|---|
| . | >50% . | ≤50% . | P . |
| Age of product, n (%) | <.001 | ||
| <48 h | 202 (86) | 37 (59.7) | |
| ≥48 h | 33 (14) | 25 (40.3) | |
| %TNC viability-7AAD, n (%) | |||
| <90% | 60 (25.5) | 27 (43.5) | .008 |
| ≥90% | 175 (74.5) | 35 (56.5) | |
| Product origin, n (%) | .03 | ||
| Domestic | 133 (56.6) | 25 (40.3) | |
| International | 102 (43.4) | 37 (59.7) | |